# Seasonal Flu Vaccine in Adult Transplant Recipients

> **NCT01258023** · PHASE2 · COMPLETED · sponsor: **HepNet Study House, German Liverfoundation** · enrollment: 122 (actual)

## Conditions studied

- Immunocompromised
- Transplanted

## Interventions

- **BIOLOGICAL:** Fluad 1x

## Key facts

- **NCT ID:** NCT01258023
- **Lead sponsor:** HepNet Study House, German Liverfoundation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-04
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2012-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01258023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01258023, "Seasonal Flu Vaccine in Adult Transplant Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01258023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*